Emergent BioSolutions: Q4 Earnings Insights

Emergent BioSolutions EBS reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Emergent BioSolutions beat estimated earnings by 5.39%, reporting an EPS of $4.5 versus an estimate of $4.27.

Revenue was up $140.20 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $2.71 which was followed by a 37.07% drop in the share price the next day.

Here's a look at Emergent BioSolutions's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.